Forbes July 30, 2024
Robert Hart

Topline

A weight loss and diabetes drug in the same class as blockbuster medicines like Ozempic and Wegovy may help stave off dementia, according to new data reported Tuesday, adding to mounting evidence the popular drugs can help treat a diverse array of conditions.

Key Facts

Could Other Glp-1 Drugs Like Ozempic And Wegovy Help Treat Alzheimer’s?

It’s not known whether more recent GLP-1 drugs like semaglutide and tirzepatide—generic names for Ozempic, Wegovy, Mounjaro and Zepbound—will have an effect on conditions like Alzheimer’s. As both belong to the same class of drug as liraglutide and act in similar ways by targeting the GLP-1 system, findings for one drug do give an indication for what may happen with the other, though...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, Pharma / Biotech, Provider
JP Morgan Annual Healthcare Conference 2025: What are the key talking points likely to be?
Biden administration proposes Medicare coverage for weight loss drugs: 10 things to know
Proposed Coverage of Anti-Obesity Drugs in Medicare and Medicaid Would Expand Access to Millions of People with Obesity
Medicare and Medicaid would cover Ozempic, Wegovy under new Biden rule
New Proposal Aims to Expand Medicaid and Medicare Coverage for Obesity Drugs

Share This Article